Imatinib Mesylate in Treating Patients With Salivary Gland Cancer

Clinical trial NCT00045669 · COMPLETED

Trial details

NCT number: NCT00045669
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2002-07-01
Primary completion: 2004-01-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.